When does Zimmer Biomet report earnings?
Zimmer Biomet Holdings, Inc. · end-of-day data as of Nov 13, 2026
- P/E vs sector-18.9%
- Trendbullish
- MAs4 of 4
- MA20×50Golden 8d ago
- MACD0.34
- Sector▲ +15.9%
- Earnings in88d
- P/E26.1x
- RSI56
- Support-0.8%
- Resistance+3.3%
- Off 52w high-8.3%
- Volume1.0x
- Bollingerupper half
- News0.00
- ConsensusHold · 28
- PT$107.42 +4.1%
- 52w range$79–$113
- ATR+3.2%
- Off ATH-41.0%
- P/E vs own+13.2%
- Insiders-$824K
Updates with the 15-min delayed price. Not a forecast or investment advice.
![]()
The stock around its reports
Last close $103.21 · -3.8% over 2y · E earnings · D dividend · S split · A analyst rating change
Quarterly results
Q3 FY2026: Revenue +3.1% year over year, free cash flow 18.1% of revenue, operating margin 14.9%.
| Q3 FY2026 | Sep 30, 2026 | $2.06B | 1.00 | $373M | 71.2% | 14.9% | 9.3% |
| Q2 FY2026 | Jun 30, 2026 | $2.18B | 1.03 | $331M | 70.8% | 15.0% | 9.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.09B | 1.22 | $284M | 72.4% | 17.9% | 11.4% |
| Q4 FY2025 | Dec 31, 2025 | $2.24B | 0.70 | — | 64.7% | 12.8% | 6.2% |
| Q3 FY2025 | Sep 30, 2025 | $2B | 1.16 | — | 72.1% | 17.6% | 11.5% |
| Q2 FY2025 | Jun 30, 2025 | $2.08B | 0.77 | $298M | 71.5% | 14.4% | 7.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.91B | 0.91 | $336M | 71.2% | 15.3% | 9.5% |
| Q4 FY2024 | Dec 31, 2024 | $2.02B | 1.20 | $421M | 71.0% | 19.2% | 11.8% |